Last reviewed · How we verify

Lycored (LYCOPENE)

discontinued Small molecule

Lycored works by interacting with cell membranes to neutralize free radicals and reduce oxidative stress.

Lycored is a lycopene-based small molecule developed by a company, currently owned by a pharmaceutical company. It is used to treat various conditions, although its exact target and approved indications are unknown. The commercial status of Lycored is unclear, with no information available on its patent status or generic availability. As a small molecule, Lycored is designed to interact with specific biological pathways to produce its therapeutic effects. Further research is needed to fully understand its pharmacological properties and clinical applications.

At a glance

Generic nameLYCOPENE
Drug classlycopene
ModalitySmall molecule
Therapeutic areaOther
Phasediscontinued

Mechanism of action

Think of Lycored like a shield for your cells. It helps protect them from damage caused by free radicals, which are unstable molecules that can harm your cells and contribute to diseases. By neutralizing these free radicals, Lycored helps keep your cells healthy and functioning properly.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: